Stockreport

Microbot Medical® Announces FDA Submission for the Commercialization of the LIBERTY® Endovascular Robotic System

Microbot Medical Inc.  (MBOT) 
Last microbot medical inc. earnings: 11/14 03:34 pm Check Earnings Report
US:NASDAQ Investor Relations: microbotmedical.com/investors
PDF FDA 510(k) Submission Follows the Successful Completion of the Pivotal Human Clinical Trial FDA 510(k) Clearance Anticipated During the Second Quarter of 2025 Company [Read more]